Clinical Trials on ROP Threshold in Belgium

Total 3 results

  • Bayer
    Regeneron Pharmaceuticals
    Completed
    Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy (FIREFLEYE)
    Retinopathy of Prematurity (ROP)
    Spain, Singapore, Hong Kong, Korea, Republic of, Malaysia, Japan, Taiwan, Sweden, Portugal, Belgium, Argentina, Bulgaria, Italy, Austria, Brazil, Czechia, Greece, Hungary, Israel, Netherlands, Poland, Romania, Russian Federation, Slov... and more
  • Novartis Pharmaceuticals
    Completed
    Rainbow Extension Study (RainbowExt)
    Retinopathy of Prematurity (ROP)
    United States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Hungary, India, Italy, Japan, Malaysia, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United Kingdom, Lithuania, Estonia
  • Bayer
    Regeneron Pharmaceuticals
    Active, not recruiting
    Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 (FIREFLEYE next)
    Retinopathy of Prematurity (ROP)
    Spain, Korea, Republic of, Singapore, Malaysia, Japan, Taiwan, Bulgaria, Italy, Argentina, Czechia, Greece, Israel, Netherlands, Portugal, Romania, Russian Federation, Slovakia, Sweden, Turkey, United Kingdom, Ukraine, Hungary, Belgium and more

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe